These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17895299)

  • 1. Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment.
    Ramos-Barrón A; Piñera-Haces C; Gómez-Alamillo C; Santiuste-Torcida I; Ruiz JC; Buelta-Carrillo L; Merino R; de Francisco AL; Arias M
    Lupus; 2007; 16(10):775-81. PubMed ID: 17895299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
    Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
    Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
    Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
    Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice.
    Lacotte S; Dumortier H; Décossas M; Briand JP; Muller S
    J Immunol; 2010 Apr; 184(7):3937-45. PubMed ID: 20181885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies.
    Sthoeger ZM; Zinger H; Mozes E
    Ann Rheum Dis; 2003 Apr; 62(4):341-6. PubMed ID: 12634234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.
    Barrat FJ; Meeker T; Chan JH; Guiducci C; Coffman RL
    Eur J Immunol; 2007 Dec; 37(12):3582-6. PubMed ID: 18034431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F1 mice.
    Viau M; Zouali M
    Mol Immunol; 2005 May; 42(7):849-55. PubMed ID: 15829273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model.
    Stoll ML; Price KD; Silvin CJ; Jiang F; Gavalchin J
    J Autoimmun; 2007 Aug; 29(1):30-7. PubMed ID: 17459659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice.
    Tarkowski A; Gunnarsson K; Stålhandske T
    Immunology; 1986 Dec; 59(4):589-94. PubMed ID: 3804379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and reversal of lupus in NZB/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer.
    Ye X; Zhu T; Bastacky S; McHale T; Li J; Xiao X
    Arthritis Rheum; 2005 Dec; 52(12):3975-86. PubMed ID: 16329128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice.
    Ikehara S; Shimamura K; Aoyama T; Fujii S; Hamashima Y
    Immunology; 1985 Aug; 55(4):595-600. PubMed ID: 4018844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
    Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
    Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
    Bahjat FR; Pine PR; Reitsma A; Cassafer G; Baluom M; Grillo S; Chang B; Zhao FF; Payan DG; Grossbard EB; Daikh DI
    Arthritis Rheum; 2008 May; 58(5):1433-44. PubMed ID: 18438845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW)F1 mice.
    Yamauchi T; Ishibashi A; Shikata K; Tokuhara N; Seino K; Kobayashi S; Nagai M
    J Pharmacol Exp Ther; 2005 Mar; 312(3):938-44. PubMed ID: 15615868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromosome aberrations in F1 (NZBxNZW) mice--an experimental model of systemic lupus erythematosus].
    Skazkina OIa; Lil'p IG; Pleskovskaia GN; Tugolukova SS; Korogodina IuV
    Tsitol Genet; 1984; 18(6):458-9. PubMed ID: 6441320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
    Gunn HC
    Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice.
    Ramos MA; Piñera C; Setién MA; Buelta L; de Cos MA; de Francisco AL; Merino R; Arias M
    Nephrol Dial Transplant; 2003 May; 18(5):878-83. PubMed ID: 12686658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation.
    Choi EW; Shin IS; Park SY; Park JH; Kim JS; Yoon EJ; Kang SK; Ra JC; Hong SH
    Arthritis Rheum; 2012 Jan; 64(1):243-53. PubMed ID: 21904997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.